Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer
Frank A. Sinicrope(Mayo Clinic in Arizona), Hisato Kawakami(Tohoku University), Pashtoon Murtaza Kasi(Cornell University), Koichi Okamoto(Mayo Clinic in Arizona)
Cited by 115
Related Papers
Colorectal cancer
|The Lancet|2019|5k
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer
|JAMA|2018|580
DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
|JNCI Journal of the National Cancer Institute|2011|527
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial
|The Lancet Oncology|2021|411
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening
|New England Journal of Medicine|2024|385